Details for New Drug Application (NDA): 210652
✉ Email this page to a colleague
The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Summary for 210652
Tradename: | NEOSTIGMINE METHYLSULFATE |
Applicant: | Indoco |
Ingredient: | neostigmine methylsulfate |
Patents: | 0 |
Pharmacology for NDA: 210652
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210652
Suppliers and Packaging for NDA: 210652
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210652 | ANDA | Indoco Remedies Limited | 14445-413 | 14445-413-01 | 10 CARTON in 1 PACKAGE (14445-413-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (14445-413-10) / 10 mL in 1 VIAL, MULTI-DOSE |
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210652 | ANDA | Indoco Remedies Limited | 14445-414 | 14445-414-01 | 10 CARTON in 1 PACKAGE (14445-414-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (14445-414-10) / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/10ML (0.5MG/ML) | ||||
Approval Date: | Oct 1, 2021 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/10ML (1MG/ML) | ||||
Approval Date: | Oct 1, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription